244 related articles for article (PubMed ID: 30558294)
21. Coumarins from Angelica decursiva inhibit α-glucosidase activity and protein tyrosine phosphatase 1B.
Ali MY; Jannat S; Jung HA; Jeong HO; Chung HY; Choi JS
Chem Biol Interact; 2016 May; 252():93-101. PubMed ID: 27085377
[TBL] [Abstract][Full Text] [Related]
22. The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications.
Teimouri M; Hosseini H; ArabSadeghabadi Z; Babaei-Khorzoughi R; Gorgani-Firuzjaee S; Meshkani R
J Physiol Biochem; 2022 May; 78(2):307-322. PubMed ID: 34988903
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the inhibitory activity of natural tanshinones from Salvia miltiorrhiza roots on protein tyrosine phosphatase 1B.
Kim DH; Paudel P; Yu T; Ngo TM; Kim JA; Jung HA; Yokozawa T; Choi JS
Chem Biol Interact; 2017 Dec; 278():65-73. PubMed ID: 29031618
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents.
Onoda T; Li W; Higai K; Koike K
BMC Complement Altern Med; 2014 Feb; 14():64. PubMed ID: 24555682
[TBL] [Abstract][Full Text] [Related]
25. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders.
Singh S; Singh Grewal A; Grover R; Sharma N; Chopra B; Kumar Dhingra A; Arora S; Redhu S; Lather V
Bioorg Chem; 2022 Apr; 121():105626. PubMed ID: 35255350
[TBL] [Abstract][Full Text] [Related]
26. BPN, a marine-derived PTP1B inhibitor, activates insulin signaling and improves insulin resistance in C2C12 myotubes.
Xu Q; Luo J; Wu N; Zhang R; Shi D
Int J Biol Macromol; 2018 Jan; 106():379-386. PubMed ID: 28811203
[TBL] [Abstract][Full Text] [Related]
27. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes.
Qian S; Zhang M; He Y; Wang W; Liu S
Future Med Chem; 2016 Jul; 8(11):1239-58. PubMed ID: 27357615
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of protein tyrosine phosphatase 1B by flavonoids: A structure - activity relationship study.
Proença C; Freitas M; Ribeiro D; Sousa JLC; Carvalho F; Silva AMS; Fernandes PA; Fernandes E
Food Chem Toxicol; 2018 Jan; 111():474-481. PubMed ID: 29175190
[TBL] [Abstract][Full Text] [Related]
30. Pyrazoles as novel protein tyrosine phosphatase 1B (PTP1B) inhibitors: An in vitro and in silico study.
Rocha S; Lucas M; Silva VLM; Gomes PMO; Silva AMS; Araújo AN; Aniceto N; Guedes RC; Corvo ML; Fernandes E; Freitas M
Int J Biol Macromol; 2021 Jun; 181():1171-1182. PubMed ID: 33857515
[TBL] [Abstract][Full Text] [Related]
31. PTP1B inhibitors for type 2 diabetes treatment: a patent review (2011 - 2014).
Tamrakar AK; Maurya CK; Rai AK
Expert Opin Ther Pat; 2014 Oct; 24(10):1101-15. PubMed ID: 25120222
[TBL] [Abstract][Full Text] [Related]
32. QSAR studies of PTP1B inhibitors: recent advances and perspectives.
Luan F; Xu X; Liu HT; Cordeiro MN; Zhang XY
Curr Med Chem; 2012; 19(25):4208-17. PubMed ID: 22834811
[TBL] [Abstract][Full Text] [Related]
33. Identification of protein tyrosine phosphatase 1B (PTP1B) inhibitors through De Novo Evoluton, synthesis, biological evaluation and molecular dynamics simulation.
Wu J; Ma Y; Zhou H; Zhou L; Du S; Sun Y; Li W; Dong W; Wang R
Biochem Biophys Res Commun; 2020 May; 526(1):273-280. PubMed ID: 32209254
[TBL] [Abstract][Full Text] [Related]
34. Protein Tyrosine Phosphatase 1B Inhibitors of
Zhang Y; Liu H; Lv T; Xiao M; Gao G
Molecules; 2024 Jun; 29(12):. PubMed ID: 38930797
[No Abstract] [Full Text] [Related]
35. Furanoterpenes, new types of protein tyrosine phosphatase 1B inhibitors, from two Indonesian marine sponges, Ircinia and Spongia spp.
Abdjul DB; Yamazaki H; Kanno SI; Wewengkang DS; Rotinsulu H; Sumilat DA; Ukai K; Kapojos MM; Namikoshi M
Bioorg Med Chem Lett; 2017 Mar; 27(5):1159-1161. PubMed ID: 28189419
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and
Yang L; Chen F; Gao C; Chen J; Li J; Liu S; Zhang Y; Wang Z; Qian S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):152-164. PubMed ID: 31742469
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, biological evaluation and molecular dynamics studies of 4-thiazolinone derivatives as protein tyrosine phosphatase 1B (PTP1B) inhibitors.
Liu WS; Wang RR; Yue H; Zheng ZH; Lu XH; Wang SQ; Dong WL; Wang RL
J Biomol Struct Dyn; 2020 Aug; 38(13):3814-3824. PubMed ID: 31490104
[TBL] [Abstract][Full Text] [Related]
38. In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B.
Ottanà R; Paoli P; Cappiello M; Nguyen TN; Adornato I; Del Corso A; Genovese M; Nesi I; Moschini R; Naß A; Wolber G; Maccari R
Molecules; 2021 Jan; 26(2):. PubMed ID: 33435264
[TBL] [Abstract][Full Text] [Related]
39. Protein tyrosine phosphatase 1B inhibitors from a marine-derived fungal strain
Kim DC; Minh Ha T; Sohn JH; Yim JH; Oh H
Nat Prod Res; 2020 Mar; 34(5):675-682. PubMed ID: 30445849
[TBL] [Abstract][Full Text] [Related]
40. Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B.
Ottanà R; Paoli P; Lori G; Adornato I; Previti S; Naß A; Wolber G; Maccari R
Bioorg Chem; 2019 Nov; 92():103211. PubMed ID: 31491569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
